SK83697A3 - Piperazine-2,5-dione derivatives as modulators of multi-drug resistance - Google Patents
Piperazine-2,5-dione derivatives as modulators of multi-drug resistance Download PDFInfo
- Publication number
- SK83697A3 SK83697A3 SK836-97A SK83697A SK83697A3 SK 83697 A3 SK83697 A3 SK 83697A3 SK 83697 A SK83697 A SK 83697A SK 83697 A3 SK83697 A3 SK 83697A3
- Authority
- SK
- Slovakia
- Prior art keywords
- phenyl
- ethyl
- dimethoxy
- isoquinolyl
- tetrahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9426224.3A GB9426224D0 (en) | 1994-12-23 | 1994-12-23 | Pharmaceutical compounds |
| PCT/GB1995/003027 WO1996020190A1 (en) | 1994-12-23 | 1995-12-22 | Piperazine 2,5 dione derivatives as modulators of multi-drug resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK83697A3 true SK83697A3 (en) | 1998-05-06 |
Family
ID=10766589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK836-97A SK83697A3 (en) | 1994-12-23 | 1995-12-22 | Piperazine-2,5-dione derivatives as modulators of multi-drug resistance |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0799222A1 (no) |
| JP (1) | JPH10511384A (no) |
| CN (1) | CN1175253A (no) |
| AU (1) | AU698828B2 (no) |
| BG (1) | BG101602A (no) |
| BR (1) | BR9510410A (no) |
| CA (1) | CA2207500A1 (no) |
| CZ (1) | CZ190097A3 (no) |
| FI (1) | FI972660A (no) |
| GB (1) | GB9426224D0 (no) |
| HU (1) | HUT77943A (no) |
| IL (1) | IL116525A0 (no) |
| NO (1) | NO972937D0 (no) |
| NZ (1) | NZ297847A (no) |
| PL (1) | PL320916A1 (no) |
| SK (1) | SK83697A3 (no) |
| TW (1) | TW358094B (no) |
| WO (1) | WO1996020190A1 (no) |
| ZA (1) | ZA9510909B (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
| HUP0001531A3 (en) * | 1996-10-18 | 2000-09-28 | Xenova Ltd Slough | Anthranilic acid derivatives as multi drug resistance modulators |
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| DE69929704T2 (de) | 1998-10-08 | 2006-07-20 | Smithkline Beecham Plc, Brentford | Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel) |
| BRPI0017067B8 (pt) * | 2000-01-18 | 2021-05-25 | Beyondspring Pharmaceuticals Inc | inibidor de divisão de célula, desidrogenase, método para a produção de um inibidor de divisão de célula e composto |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| ES2295695T3 (es) | 2002-08-02 | 2008-04-16 | Nereus Pharmaceuticals, Inc. | Deshidrofenilahistinas y sus analogos y la sintesis de deshidrofenilahistinas y sus analogos. |
| US7935704B2 (en) | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| US8129527B2 (en) | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| CN103396372B (zh) * | 2013-08-09 | 2015-05-20 | 中国科学院南海海洋研究所 | 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用 |
| BR112017018964A2 (pt) | 2015-03-06 | 2018-05-22 | Beyondspring Pharmaceuticals Inc | uso de plinabulin e métodos para tratar tumor cerebral |
| RU2736045C2 (ru) | 2015-03-06 | 2020-11-11 | Бейондспринг Фармасьютикалс, Инк. | Способ лечения рака, ассоциированного с мутацией ras |
| WO2017011399A1 (en) | 2015-07-13 | 2017-01-19 | Beyondspring Pharmaceuticals, Inc | Plinabulin compositions |
| AU2017217426B2 (en) | 2016-02-08 | 2022-12-01 | Beyondspring Pharmaceuticals, Inc. | Compositions containing tucaresol or its analogs |
| BR112018074990A2 (pt) | 2016-06-06 | 2019-03-12 | Beyondspring Pharmaceuticals, Inc. | composição, usos e método para reduzir neutropenia |
| CN110431135A (zh) | 2017-01-06 | 2019-11-08 | 大连万春布林医药有限公司 | 微管蛋白结合化合物及其治疗用途 |
| US11400086B2 (en) | 2017-02-01 | 2022-08-02 | Beyondspring Pharmaceuticals, Inc. | Method of reducing chemotherapy-induced neutropenia |
| EP3743074A4 (en) | 2018-01-24 | 2021-12-15 | Beyondspring Pharmaceuticals Inc. | COMPOSITION AND METHOD FOR REDUCING THROMBOCYTOPENIA BY THE ADMINISTRATION OF PLINABULINE |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0649410B1 (en) * | 1992-07-10 | 1997-05-02 | Laboratoires Glaxo Sa | Anilide derivatives |
| GB9217331D0 (en) * | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
-
1994
- 1994-12-23 GB GBGB9426224.3A patent/GB9426224D0/en active Pending
-
1995
- 1995-12-21 ZA ZA9510909A patent/ZA9510909B/xx unknown
- 1995-12-22 IL IL11652595A patent/IL116525A0/xx unknown
- 1995-12-22 EP EP95941797A patent/EP0799222A1/en not_active Withdrawn
- 1995-12-22 JP JP8520301A patent/JPH10511384A/ja active Pending
- 1995-12-22 WO PCT/GB1995/003027 patent/WO1996020190A1/en not_active Application Discontinuation
- 1995-12-22 HU HU9800398A patent/HUT77943A/hu unknown
- 1995-12-22 CN CN95197672A patent/CN1175253A/zh active Pending
- 1995-12-22 NZ NZ297847A patent/NZ297847A/en unknown
- 1995-12-22 CZ CZ971900A patent/CZ190097A3/cs unknown
- 1995-12-22 CA CA002207500A patent/CA2207500A1/en not_active Abandoned
- 1995-12-22 BR BR9510410-0A patent/BR9510410A/pt not_active Application Discontinuation
- 1995-12-22 SK SK836-97A patent/SK83697A3/sk unknown
- 1995-12-22 PL PL95320916A patent/PL320916A1/xx unknown
- 1995-12-22 AU AU43100/96A patent/AU698828B2/en not_active Ceased
- 1995-12-23 TW TW084113836A patent/TW358094B/zh active
-
1997
- 1997-06-11 BG BG101602A patent/BG101602A/xx unknown
- 1997-06-19 FI FI972660A patent/FI972660A/fi unknown
- 1997-06-23 NO NO972937A patent/NO972937D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1175253A (zh) | 1998-03-04 |
| CA2207500A1 (en) | 1996-07-04 |
| FI972660A0 (fi) | 1997-06-19 |
| ZA9510909B (en) | 1996-08-30 |
| BG101602A (en) | 1998-02-27 |
| NZ297847A (en) | 1999-04-29 |
| GB9426224D0 (en) | 1995-02-22 |
| EP0799222A1 (en) | 1997-10-08 |
| WO1996020190A1 (en) | 1996-07-04 |
| PL320916A1 (en) | 1997-11-10 |
| HUT77943A (hu) | 1998-12-28 |
| FI972660A (fi) | 1997-08-22 |
| IL116525A0 (en) | 1996-03-31 |
| AU4310096A (en) | 1996-07-19 |
| JPH10511384A (ja) | 1998-11-04 |
| NO972937L (no) | 1997-06-23 |
| CZ190097A3 (cs) | 1998-01-14 |
| NO972937D0 (no) | 1997-06-23 |
| AU698828B2 (en) | 1998-11-05 |
| BR9510410A (pt) | 1999-09-08 |
| TW358094B (en) | 1999-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK83697A3 (en) | Piperazine-2,5-dione derivatives as modulators of multi-drug resistance | |
| ES2443127T3 (es) | Nuevos derivados tricíclicos o sales de éstos farmacéuticamente aceptables, su procedimiento de fabricación y composiciones farmacéuticas que los contienen | |
| KR101311757B1 (ko) | 2-아미노-7,8-디히드로-6ｈ-피리도［4,3-ｄ］피리미딘-5-온 | |
| KR20080006614A (ko) | 증식 질환의 치료에 유용한 ｈｓｐ90 억제제인2-아미노-퀴나졸린-5-온 | |
| JP2003505373A (ja) | ビフェニル誘導体、その製法及び薬剤としての使用 | |
| CN106536491B (zh) | 作为盐皮质激素受体调节剂的苯并噁嗪酮酰胺 | |
| KR19990087550A (ko) | 4-아미노-피리미딘 유도체, 이 화합물을 함유한 약제, 이의용도 및 이의 제조 방법 | |
| MXPA03001725A (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su uso y metodos para su produccion. | |
| JP2013502444A (ja) | キナーゼ阻害剤としての５，６−ビシクロヘテロアリール含有尿素化合物 | |
| JP6704422B2 (ja) | キナゾリン誘導体の塩およびその製造方法 | |
| WO2003099765A1 (fr) | Derive de $g(b)-alanine et utilisation correspondante | |
| WO2001010439A1 (fr) | Antagonistes d'amine cyclique ccr3 | |
| TW202003466A (zh) | 人類整合素α４β７拮抗劑 | |
| JPH10500425A (ja) | 薬学的なジケトピペラジン化合物 | |
| TW201105325A (en) | 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides | |
| JP2006503799A (ja) | グアニジノ化合物 | |
| JP2010504945A (ja) | キノリノン誘導体 | |
| JPWO2009041559A1 (ja) | インダゾールアクリル酸アミド化合物 | |
| TW200846330A (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof | |
| EP3212653A2 (en) | Active acrylamides | |
| EP0799210B1 (en) | Piperazine-2,5-dione derivatives as modulators of multidrug resistance | |
| JP2004519486A (ja) | クロマン誘導体、その製造方法及びその抗腫瘍剤としての使用 | |
| EA008623B1 (ru) | Замещённые в положении 6 индолиноновые производные, их получение и их применение в качестве лекарственных средств | |
| WO2010064737A1 (ja) | 複素環化合物およびその用途 | |
| JPH06184074A (ja) | １−アルコキシナフタレン−２−カルボキサミド誘導体、その製法並びに該誘導体を含有する医薬組成物 |